SpaceX posted nearly $5 billion loss in 2025, The Information reports

Key event: SpaceX reportedly posted a near $5 billion loss in 2025 on revenue of more than $18.5 billion, a figure that the report says includes the February acquisition of Elon Musk’s xAI. Reuters earlier reported SpaceX generated about $8 billion in profit on $15–$16 billion revenue the prior year; the company confidentially filed for a U.S. listing in March and is reportedly targeting a potential valuation above $1.75 trillion. The disclosure is material to investors assessing SpaceX’s IPO outlook and valuation, but is mixed and does not constitute a market-wide shock.

Analysis

A large, high-profile pre-IPO technology conglomerate showing material near-term operating strain (driven by an AI unit and heavy capex ambitions) will pressure comps and re-price investor expectations across both the space launch/satellite value chain and AI hardware/software vendors. Expect two distinct market regimes over 3–12 months: a near-term premium maintained by IPO hype and retail interest, and a mid-term re-rating once S-1 detail, lockup expiries and cash-burn cadence become visible to institutional holders.

Second-order winners are vendors with diversified, defense-anchored revenue streams and firms selling AI infrastructure components (GPUs, power, cooling) regardless of whether compute is terrestrial or conceptualized for edge/orbit; second-order losers are smaller, single-customer launch suppliers and late-stage private companies whose valuations leaned on the expectation of a blockbuster public exit. This dynamic will amplify dispersion: expect 20–40% relative underperformance from highly concentrated commercial-launch names versus broad aerospace primes within 6–9 months if order momentum cools.

Key catalysts to watch are the S-1 (cash runway, related-party transactions), reported capex allocation between launch vs AI projects, and any announced equity or debt raises — each can shift funding runway by 6–24 months. Tail risks include a renewed retail mania that keeps multiples elevated despite weak fundamentals (short-term), or a macro tightening shock that forces a repricing of all loss-making, capital-intensive tech IPOs (medium-term).

Key Decisions for Investors

• Long NVDA Jan-2027 LEAP call spread (buy 1, sell 1 higher strike) — 6–18 month horizon. Rationale: secular GPU demand for AI grows regardless of where AI assets sit; structure caps cost while retaining asymmetric upside. Risk/reward: cost-limited to premium (downside), upside ~2–4x if enterprise AI monetization accelerates.
• Pair trade: Long LMT (2–4% portfolio) / Short RKLB (or similar small-cap commercial launcher) (3–9 month horizon). Rationale: defense primes are diversified beneficiaries if commercial order flow softens; small launchers are levered to a single-customer/orderbook narrative. Risk/reward: expect 15–30% relative outperformance; hedge size to limit single-name blowups from successful commercial cadence surprises.
• Event-driven short: Buy 3–6 month puts on IPO-focused ETFs (e.g., IPO) or use a small short position in high-multiple space/AI public comps after S-1 release. Rationale: S-1 transparency historically triggers 10–25% downside re-rates in overhyped IPO cohorts. Risk/reward: premium paid vs potential 2–4x payoff if market de-rates the cohort.
• Contrarian tactical long: Accumulate high-quality small launch/satellite names on >25% pullbacks tied to headline volatility, size into technical supports and confirmed backlog retention (12–36 month hold). Rationale: long-term TAM remains large; use pullbacks to buy optionality where balance sheets show >12 months runway. Risk/reward: high idiosyncratic risk short-term, but 3x+ upside if commercialization and backlog convert.